MatthewJamesCraigMD

PubMed

• Desmopression is an effective adjunct treatment for reversing excessive hyponatremia overcorrection.
  Gharaibeh, K. A.,Craig, M. J.,Koch, C. A.,Lerant, A. A.,Fülöp, T.,Csongrádi, E.> ;World J Clin Cases. 2013 Dec 05
• IL-4 induces proliferation in prostate cancer PC3???cells under nutrient-depletion stress through the activation of the JNK-pathway and survivin upregulation.
  Roca, H., Craig, M.J., Ying, C., Varsos, Z.S., Czarnieski, P., Alva, A.S., Hernandez, J., Fuller, D., Daignault, S., Healy, P.N., Pienta, K.J.> ;J Cell Biochem. 2012 May
• AT-101 (R-(-)-gossypol acetic acid) enhances the effectiveness of androgen deprivation therapy in the VCaP prostate cancer model.
  McGregor N, Patel L, Craig M, Weidner S, Wang S, Pienta KJ> ;J. Cell. Biochem.. 2010-08-01
• CCL2 and interleukin-6 promote survival of human CD11b+ peripheral blood mononuclear cells and induce M2-type macrophage polarization.
  Roca, H., Varsos, Z.S., Sud, S., Craig, M.J., Ying, C., Pienta, K.J.> ;J Biol Chem. 2009-12-04
• Co-inoculation of prostate cancer cells with U937 enhances tumor growth and angiogenesis in vivo.
  Craig M, Ying C, Loberg RD> ;J. Cell. Biochem.. 2008-01-01
• PAR1-mediated RhoA activation facilitates CCL2-induced chemotaxis in PC-3 cells.
  Loberg RD, Tantivejkul K, Craig M, Neeley CK, Pienta KJ> ;J. Cell. Biochem.. 2007-08-01
• CCL2 (Monocyte Chemoattractant Protein-1) in cancer bone metastases.
  Craig, M. J., Loberg, R. D.> ;Cancer Metastasis Rev. 2006 Dec
• The chemokine CCL2 increases prostate tumor growth and bone metastasis through macrophage and osteoclast recruitment.
  Mizutani, K., Sud, S., McGregor, N. A., Martinovski, G., Rice, B. T., Craig, M. J., Varsos, Z. S., Roca, H., Pienta, K. J.> ;Neoplasia. 2009 Nov 01
• Join now to see all